Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study.
BACKGROUND
The incidence of recurrent tinea infections after oral terbinafine therapy is on the rise.


OBJECTIVE
This study aims to identify the appearance of incomplete cure and relapse after 2-week oral terbinafine therapy in tinea corporis and/or tinea cruris.


METHODS
A total of 100 consecutive patients clinically and mycologically diagnosed to have tinea corporis and/or tinea cruris were included in the study. The enrolled patients were administered oral terbinafine 250 mg once daily for 2 weeks. All clinically cured patients were then followed up for 12 weeks to look for any relapse/cure.


RESULTS
The common dermatophytes grown on culture were Trichophyton rubrum and Trichophyton tonsurans in 55% and 20% patients, respectively. At the end of 2-week oral terbinafine therapy, 30% patients showed a persistent disease on clinical examination while 35% patients showed a persistent positive fungal culture (persisters) at this time. These culture positive patients included all the clinically positive cases. Rest of the patients (65/100) demonstrated both clinical and mycological cure at this time (cured). Over the 12-week follow-up, clinical relapse was seen in 22 more patients (relapse) among those who had shown clinical and mycological cure at the end of terbinafine therapy. Thus, only 43% patients could achieve a long-term clinical and mycological cure after 2 weeks of oral terbinafine treatment. Majority of the relapses (16/22) were seen after 8 weeks of completion of treatment. There was no statistically significant difference in the body surface area involvement or the causative organism involved between the cured, persister, or relapse groups.


CONCLUSIONS
Incomplete mycological cure as well as relapse is very common after standard (2-week) terbinafine therapy in our patients of tinea cruris/corporis.
Department of Dermatology, Government Medical College, Srinagar, Jammu and Kashmir, India.
Imran
I
Majid
Department of Dermatology, Government Medical College, Srinagar, Jammu and Kashmir, India.
Gousia
G
Sheikh
Department of Dermatology, Government Medical College, Srinagar, Jammu and Kashmir, India.
Farhath
F
Kanth
Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir, India.
Rubeena
R
Hakak
Dermatophytosis; terbinafine resistance; tinea infections
Curr Opin Pediatr. 2001 Aug;13(4):331-5
11717558
J Clin Microbiol. 1999 Apr;37(4):920-4
10074502
Indian J Pathol Microbiol. 1999 Oct;42(4):455-62
11127378
Indian J Dermatol Venereol Leprol. 2002 Sep-Oct;68(5):259-61
17656961
Pathology. 1999 Nov;31(4):395-7
10643013
Drugs. 1999 Jul;58(1):179-202
10439936
Indian J Dermatol. 2011 Jan;56(1):121-2
21572814
Iran J Pharm Res. 2013 Summer;12(3):537-45
24250660
Cutis. 2001 Jul;68(1 Suppl):15-22
11499330
Indian J Med Microbiol. 2004 Oct-Dec;22(4):273-4
17642757
J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S104-12
11044285
Mycopathologia. 1997-1998;140(3):129-35
9691500
Indian J Dermatol. 2014 May;59(3):262-7
24891657
Br J Dermatol. 1994 Nov;131(5):684-6
7999601
Clin Exp Dermatol. 1990 May;15(3):210-6
2194715
Antimicrob Agents Chemother. 2006 Jun;50(6):2234-6
16723593
Mycoses. 2008 Sep;51 Suppl 4:2-15
18783559
Antimicrob Agents Chemother. 2005 Jul;49(7):2840-4
15980358
Med Mycol. 2000;38 Suppl 1:269-79
11204155
Biochem Biophys Res Commun. 1993 Jun 15;193(2):718-21
8512570
Mycopathologia. 2008 Nov-Dec;166(5-6):369-83
18478356
Br J Dermatol. 1992 Feb;126 Suppl 39:2-7
1543672
Cutis. 2001 Jul;68(1 Suppl):23-9
11499331
Antimicrob Agents Chemother. 2003 Jan;47(1):82-6
12499173
Arch Dermatol. 1989 Nov;125(11):1537-9
2684023
Med Mycol. 2007 Mar;45(2):131-41
17365649
Infect Dis Clin North Am. 2003 Mar;17(1):87-112
12751262
Dermatol Clin. 2003 Jul;21(3):395-400, v
12956194
Clin Cosmet Investig Dermatol. 2009 Apr 21;2:49-63
21436968
Indian J Dermatol Venereol Leprol. 1995 Jul-Aug;61(4):209-11
20952956
Br J Dermatol. 1994 Apr;130 Suppl 43:1-3
8186133
J Am Acad Dermatol. 2004 May;50(5):748-52
15097959
J Med Microbiol. 2000 Jun;49(6):493-7
10847201
Indian J Dermatol Venereol Leprol. 2003 Jul-Aug;69(4):281-3
17642912
J Med Assoc Thai. 1993 Jul;76(7):388-93
8089640
Med J Armed Forces India. 2003 Apr;59(2):114-6
27407482